vijayakanth pagadala, PhD

Dr. Pagadala received his PhD in Biochem & MolBio from Rosalind Franklin University, Illinois and Post Doctoral training at NIEHS-NIH and UNC School of Pharmacy in North Carolina. Currently as a Chief Operating Officer at Glycan Therapeutics Dr. Pagadala is implementing multiple projects aimed to develop therapeutic products for humans and services for Biomedical research. Dr. Pagadala holds adjunct faculty appointment at UNC Chapel Hill and continues to receive funding from NIH as a Principal Investigator on multiple grants. With experience in non-profit, academia and industry settings Dr. Pagadala shows operational understanding of variety of institution settings. His scientific knowledge spans Biotechnology, Microbiology, enzymology, structural biology, bioenergetics, epigenetics, drug discovery and development, Bioassays, chemical and manufacturing quality control.